Serum lipid traits and the risk of dementia: A cohort study of 254,575 women and 214,891 men in the UK Biobank
- PMID: 36247924
- PMCID: PMC9561731
- DOI: 10.1016/j.eclinm.2022.101695
Serum lipid traits and the risk of dementia: A cohort study of 254,575 women and 214,891 men in the UK Biobank
Abstract
Background: Serum lipid traits are associated with cardiovascular disease, but uncertainty remains regarding their associations with dementia.
Methods: From 2006 to 2010, 254,575 women and 214,891 men were included from the UK Biobank. Cox regression estimated overall and sex-specific hazard ratios (HRs) for apolipoprotein A (ApoA), apolipoprotein B (ApoB), HDL, LDL, total cholesterol, triglycerides, lipoprotein A, and various lipid ratios, by quarters and standard deviation (SD) higher, associated with all-cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD). Subgroup analyses by age and social deprivation were conducted.
Findings: Over 11·8 years (median), 3734 all-cause dementia (1,716 women), 1231 AD and 929 VaD were recorded. Compared to respective lowest quarters, highest quarter of ApoA was associated with lower dementia risk (HR, [95% confidence interval (95% CI)]: 0·77 [0·69, 0·86]) while the highest quarter of ApoB was associated with greater risk (HR, 1·12 [1·01, 1·24]). Higher HDL/ApoA and ApoB/ApoA, were associated with greater risk of dementia (HR, 1·12 [1·00, 1·25], per standard deviation (SD), 1.23 [1·11, 1·37], per SD, respectively), LDL/ApoB was inversely associated (HR, 0·85 [0·76, 0·94], per SD. Higher triglycerides was associated with higher dementia risk in <60 years, but the inverse was observed for ≥60 years. Similar associations were observed for VaD and AD.
Interpretation: Apolipoproteins, and their ratios, were associated with the risk of dementia. It may be prudent to consider apolipoproteins, along with circulating cholesterol, when assessing dementia risk.
Funding: University of New South Wales, UK Medical Research Council, and the Australian National Health and Medical Research Council.
Keywords: Apolipoprotein; Dementia; Lipids; UK Biobank.
© 2022 The Authors.
Conflict of interest statement
MW does consultancy for Amgen and Freeline outside the submitted work; no support from any organisation for the submitted work; no other relationships or activities that could appear to have influenced the submitted work. All other authors have nothing to declare.
Figures




References
-
- Iwagami M, Qizilbash N, Gregson J, et al. Blood cholesterol and risk of dementia in more than 1· 8 million people over two decades: a retrospective cohort study. Lancet Healthy Longevity. 2021;2(8):e498–e506. - PubMed
-
- Ishii M. Midlife dyslipidaemia as a modifiable risk factor for later-life dementia. Lancet Healthy Longevity. 2021;2(8):e453–e454. - PubMed
-
- Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med. 2004;42(12):1355–1363. - PubMed
-
- Proitsi P. The key role of apolipoprotein B in major vascular diseases and longevity. Lancet Healthy Longevity. 2021;2(6):e302–e303. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous